Literature DB >> 25132165

Reproductive factors and non-Hodgkin lymphoma: a systematic review.

Laura Costas1, Silvia de Sanjosé2, Claire Infante-Rivard3.   

Abstract

Considerable efforts have been made to elucidate non-Hodgkin lymphoma's (NHL) etiology during the last decades. Some evidence points to an association with reproductive factors, as incidence rates for most NHL subtypes are usually higher in men than in women, and several subtypes express hormonal receptors. Although the evidence is not compelling, some studies show an inverse association with gravidity. Associations with postmenopausal hormone therapy are usually derived from unopposed estrogen use, rather than for the combination of estrogen with progestin, but these findings vary by study design. Inconsistencies in the results are likely due to the complex relationship between reproductive, biological, and sociodemographic factors, as well as to study limitations. Elucidating the role of hormonal factors should provide clues for therapeutic options and public health decisions. We provide an overview of the available evidence on reproductive factors in NHL etiology, underscoring potential sources of discrepancies and bias.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Etiology; Hormonal; Lymphoma; Non-Hodgkin; Reproductive

Mesh:

Year:  2014        PMID: 25132165     DOI: 10.1016/j.critrevonc.2014.07.004

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  9 in total

1.  Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition.

Authors:  Laura Costas; Leila Lujan-Barroso; Yolanda Benavente; Naomi E Allen; Pilar Amiano; Eva Ardanaz; Caroline Besson; Heiner Boeing; Bas Bueno-de-Mesquita; Iris Cervenka; Renée T Fortner; Agnès Fournier; Marc Gunter; Sophia Harlid; José María Huerta; Mats Jerkeman; Karin Jirström; Rudolf Kaaks; Anna Karakatsani; Kay-Tee Khaw; Anastasia Kotanidou; Eiliv Lund; Giovanna Masala; Amalia Mattiello; Beatrice Melin; Virginia Menéndez; Neil Murphy; Alexandra Nieters; Kim Overvad; Elio Riboli; Carlotta Sacerdote; Maria-Jose Sánchez; Julie A Schmidt; Sabina Sieri; Anne Tjønneland; Antonia Trichopoulou; Rosario Tumino; Roel Vermeulen; Elisabete Weiderpass; Silvia de Sanjosé; Antonio Agudo; Delphine Casabonne
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

Review 2.  Anti-CD19 Monoclonal Antibodies: a New Approach to Lymphoma Therapy.

Authors:  Fatemeh Naddafi; Fatemeh Davami
Journal:  Int J Mol Cell Med       Date:  2015

3.  Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study.

Authors:  L Costas; C Infante-Rivard; J-P Zock; M Van Tongeren; P Boffetta; A Cusson; C Robles; D Casabonne; Y Benavente; N Becker; P Brennan; L Foretova; M Maynadié; A Staines; A Nieters; P Cocco; S de Sanjosé
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

4.  Female reproductive factors and risk of lymphoid neoplasm: The Japan Public Health Center-based Prospective Study.

Authors:  Shiori Tanaka; Norie Sawada; Taiki Yamaji; Taichi Shimazu; Atsushi Goto; Motoki Iwasaki; Manami Inoue; Shoichiro Tsugane
Journal:  Cancer Sci       Date:  2019-03-09       Impact factor: 6.716

5.  Inhibition of estrogen biosynthesis enhances lymphoma growth in mice.

Authors:  Gergely Talaber; Konstantin Yakimchuk; Jiyu Guan; Jose Inzunza; Sam Okret
Journal:  Oncotarget       Date:  2016-04-12

Review 6.  The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.

Authors:  H Dean Hosgood; Marc J Gunter; Neil Murphy; Thomas E Rohan; Howard D Strickler
Journal:  Front Oncol       Date:  2018-04-16       Impact factor: 6.244

7.  Demographic risk factors for lymphoma in Australian dogs: 6201 cases.

Authors:  Peter F Bennett; Rosanne Taylor; Peter Williamson
Journal:  J Vet Intern Med       Date:  2018-10-11       Impact factor: 3.333

8.  Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.

Authors:  Xuejiao Yin; Aoshuang Xu; Fengjuan Fan; Zhenli Huang; Qianwen Cheng; Lu Zhang; Chunyan Sun; Yu Hu
Journal:  Front Oncol       Date:  2019-11-12       Impact factor: 6.244

9.  Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.

Authors:  Xuejiao Yin; Lei Chen; Fengjuan Fan; Han Yan; Yuyang Zhang; Zhenli Huang; Chunyan Sun; Yu Hu
Journal:  Front Oncol       Date:  2020-09-10       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.